Clarification of Optimal Anticoagulation Through Genetics Read more about Clarification of Optimal Anticoagulation Through Genetics
A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248 Read more about A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients Read more about A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Read more about Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer
Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke Read more about Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis Read more about BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
Major Depressive Disorder With Mixed Features - Extension Read more about Major Depressive Disorder With Mixed Features - Extension
Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET Read more about Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study Read more about SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder Read more about SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder